User contributions for Lazy

29 March 2024

• 17:2117:21, 29 March 2024 diff hist −34‎ Main Page ‎ →‎Proton radiation therapy
• 11:2811:28, 29 March 2024 diff hist +20‎ Template:PropertyTableFormat ‎No edit summary
• 09:4409:44, 29 March 2024 diff hist −2‎ Template:PropertyTableFormat ‎No edit summary
• 09:1709:17, 29 March 2024 diff hist +4‎ Template:PropertyTableFormat ‎No edit summary
• 09:1709:17, 29 March 2024 diff hist +12‎ Template:PropertyTableFormat ‎No edit summary
• 09:1409:14, 29 March 2024 diff hist +72‎ Main Page ‎ →‎Proton radiation therapy
• 09:1409:14, 29 March 2024 diff hist +302‎ N Template:PropertyTableFormat ‎ Created page with "{| class="wikitable" ! Property ! Value |- | Drug Name | {{{Has drug name}}} |- | FDA Approval | {{{Has FDA approval}}} |- | Used For | {{{Used for}}} |- | Clinical Trial Phase | {{{Clinical trial phase}}} |- ... | Toxicity Explanation | {{{Toxicity explanation}}} |- | Description | {{{Book text}}} |}"
• 09:1009:10, 29 March 2024 diff hist +4‎ Main Page ‎ →‎Proton radiation therapy
• 09:0909:09, 29 March 2024 diff hist −34‎ Main Page ‎ →‎Proton radiation therapy
• 09:0809:08, 29 March 2024 diff hist +8‎ Main Page ‎ →‎Proton radiation therapy
• 09:0709:07, 29 March 2024 diff hist 0‎ Main Page ‎ →‎Proton radiation therapy
• 09:0609:06, 29 March 2024 diff hist +5‎ Main Page ‎ →‎Proton radiation therapy
• 09:0509:05, 29 March 2024 diff hist +558‎ Main Page ‎No edit summary
• 09:0009:00, 29 March 2024 diff hist −237‎ Proton Radiation Therapy ‎No edit summary
• 08:5908:59, 29 March 2024 diff hist +1,877‎ N Proton Radiation Therapy ‎ Created page with "{{TreatmentInfo |drug_name=Proton Beam Therapy (PBT) |FDA_approval=Yes |used_for=Glioblastoma and other cancers |clinical_trial_phase=Ongoing research and clinical trials |common_side_effects=Radiation dermatitis, temporary alopecia, radiation otitis, radiation necrosis (more prevalent in PBT group) |OS_without=Data varies; traditional radiation therapies offer median OS of around 16-21 months for glioblastoma |OS_with=High-dose PBT showed a median OS of 65.6 months for..."
• 08:5008:50, 29 March 2024 diff hist +10,757‎ Main Page ‎No edit summary
• 06:1006:10, 29 March 2024 diff hist 0‎ Main Page ‎ →‎Optune (formerly NovoTTF-100A) by Novocure
• 06:1006:10, 29 March 2024 diff hist +106‎ Optune ‎No edit summary
• 06:0906:09, 29 March 2024 diff hist +274‎ Main Page ‎ →‎Optune (formerly NovoTTF-100A) by Novocure
• 06:0506:05, 29 March 2024 diff hist +1,824‎ N Optune ‎ Created page with "{{TreatmentInfo |drug_name=Optune (Optune Gio® for newer version) |FDA_approval=Approved for newly diagnosed glioblastoma in October 2015; ongoing trials for broader applications |used_for=Newly diagnosed glioblastoma, with trials for other cancers ongoing |clinical_trial_phase=Phase 3 (EF-14 Trial); Phase 3 TRIDENT trial ongoing |common_side_effects=Mild to moderate skin irritation beneath transducer arrays, thrombocytopenia, nausea, constipation, vomiting, fatigue, he..."
• 05:5705:57, 29 March 2024 diff hist +4‎ Main Page ‎No edit summary
• 05:5705:57, 29 March 2024 diff hist +2‎ Main Page ‎No edit summary
• 05:5505:55, 29 March 2024 diff hist +30‎ Main Page ‎No edit summary
• 05:5405:54, 29 March 2024 diff hist +44‎ Main Page ‎No edit summary
• 05:4705:47, 29 March 2024 diff hist −6‎ Main Page ‎No edit summary
• 05:4505:45, 29 March 2024 diff hist +1,159‎ Category:Nutraceuticals ‎ →‎Nutraceuticals and Herbals
• 05:4505:45, 29 March 2024 diff hist −24‎ CBD ‎No edit summary
• 05:4305:43, 29 March 2024 diff hist +1,431‎ Main Page ‎ →‎Nutraceuticals and Herbals
• 05:4005:40, 29 March 2024 diff hist +240‎ Main Page ‎ →‎Hormones
• 05:3905:39, 29 March 2024 diff hist +734‎ Main Page ‎ →‎Repurposed Drugs
• 05:3705:37, 29 March 2024 diff hist +1,198‎ Main Page ‎ →‎Over-the-Counter Drugs and Supplements
• 05:3605:36, 29 March 2024 diff hist +234‎ Main Page ‎No edit summary
• 05:3405:34, 29 March 2024 diff hist +1,491‎ N Category:Over-the-Counter Drugs and Supplements ‎ Created page with "The treatments discussed above generally require a physician’s cooperation in prescribing them. However, there are a number of agents available over-the-counter that have promising anti-cancer properties, and it is reasonable to believe that these can increase the chances of surviving. Some of these with supporting clinical evidence (e.g., protonpump inhibitors such as Prilosec) have been discussed above. A frequent conflict between patients and their oncologists is th..."
• 05:3105:31, 29 March 2024 diff hist −7‎ Main Page ‎ →‎Combining the Standard Treatment with Additional Agents
• 05:2905:29, 29 March 2024 diff hist +20,457‎ Main Page ‎No edit summary
• 00:4800:48, 29 March 2024 diff hist +11,296‎ Main Page ‎No edit summary Tag: Visual edit: Switched

28 March 2024

• 11:0011:00, 28 March 2024 diff hist −12‎ Main Page ‎ →‎Treatment Categories

27 March 2024

• 20:1820:18, 27 March 2024 diff hist +1,976‎ Gleevec (Imatinib) ‎No edit summary
• 20:1820:18, 27 March 2024 diff hist +5,883‎ N EGFR inhibitors: Iressa, Tarceva, and Erbitux (gefitinib, erlotinib, and ‎ Created page with " {{TreatmentInfo |drug_name=EGFR inhibitors: Iressa, Tarceva, and Erbitux (gefitinib, erlotinib, and |category=Other Chemotherapy and Cancer Drugs |book_text=cetuximab) These three drugs, which have FDA approval for several different types of cancer, have the common feature that they target a growth-signaling channel known as the epidermal growth factor. Overexpression or mutation of EGF receptors is involved in the growth many different kinds of cancer, including more..."
• 20:1820:18, 27 March 2024 diff hist +2,274‎ Bevacizumab (Avastin) ‎No edit summary
• 20:1820:18, 27 March 2024 diff hist +252‎ Procarbazine ‎No edit summary
• 20:1820:18, 27 March 2024 diff hist +793‎ Platinum Compounds ‎No edit summary
• 20:1820:18, 27 March 2024 diff hist +4,355‎ BCNU (Carmustine) and Gliadel (Carmustine Wafers) ‎No edit summary
• 20:1820:18, 27 March 2024 diff hist +1,270‎ CCNU (Lomustine) ‎No edit summary
• 20:0620:06, 27 March 2024 diff hist +2,016‎ Chloroquine and Hydroxychloroquine ‎No edit summary
• 20:0520:05, 27 March 2024 diff hist +2,202‎ N Chloroquine and Hydroxychloroquine ‎ Created page with " {{TreatmentInfo |drug_name=Chloroquine and Hydroxychloroquine |category=Repurposed Drugs |book_text=In aseries of studies conducted in Mexico City (23, 24, 25) patients received the traditional chemotherapy agent BCNU, with or without a 150 mg daily dose of chloroquine (the equivalent of 250 mg chloroquine phosphate). The results were that patients receiving chloroquine had a median survival time of 25-33 months, while those receiving BCNU alone had a median survival t..."
• 15:5015:50, 27 March 2024 diff hist +79‎ Chloroquine ‎No edit summary
• 13:5713:57, 27 March 2024 diff hist −3‎ Silibinin (an ingredient in Milk Thistle) ‎No edit summary
• 13:5613:56, 27 March 2024 diff hist +2,362‎ N Silibinin (an ingredient in Milk Thistle) ‎ Created page with "{{TreatmentInfo |drug_name=Silibinin (Silymarin) |FDA_approval=No |used_for=Liver and biliary disorders, adjunct agent in cancer treatment |clinical_trial_phase=Investigated primarily in hepatitis and cirrhosis; small studies in cancers such as acute lymphoblastic leukemia, prostate cancer, breast cancer, head and neck cancer, and hepatocellular carcinoma |common_side_effects=Few reported; mainly gastrointestinal disturbances |OS_without=Not specified |OS_with=Not specif..."
• 10:1610:16, 27 March 2024 diff hist +191‎ Main Page ‎ →‎Explore Treatments by Usefulness Rating